Etan Hillman - Allmed Solutions External Director
Director
Mr. Etan Hillman was reappointed External Director at Allium Medical Solutions Ltd effective July 14, 2019. He has held this role since July 14, 2016. His work experience includes the following roles Director at Argaman Industries Ltd, Independent Director at Peleg Nia Ltd, Independent Director at Hiron Commerce Investments and Real Estate Ltd, Director at UBank, Director at Cinema Investments Ltd and Independent Director at BioCell Ltd . He holds a BS degree in Statistics and Economics from The Hebrew University of Jerusalem and a MBA degree from New York University. since 2019.
| Age | 77 |
| Tenure | 5 years |
| Professional Marks | MBA |
| Phone | 972 4 627 7166 |
| Web | https://www.allium-medical.com |
Allmed Solutions Management Efficiency
The company has return on total asset (ROA) of (0.1121) % which means that it has lost $0.1121 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1555) %, meaning that it generated substantial loss on money invested by shareholders. Allmed Solutions' management efficiency ratios could be used to measure how well Allmed Solutions manages its routine affairs as well as how well it operates its assets and liabilities.Allmed Solutions has accumulated 2.16 M in total debt with debt to equity ratio (D/E) of 0.04, which may suggest the company is not taking enough advantage from borrowing. Allmed Solutions has a current ratio of 6.81, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Allmed Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Allmed Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Allmed Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Allmed to invest in growth at high rates of return. When we think about Allmed Solutions' use of debt, we should always consider it together with cash and equity.
Allium Medical Solutions Ltd., a medical device company, develops, manufactures, and markets minimally invasive products in Israel and internationally. Allium Medical Solutions Ltd. is headquartered in Caesarea, Israel. ALLMED SOLUTIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 40 people. Allmed Solutions (ALMD) is traded on Tel Aviv Stock Exchange in Israel and employs 46 people. Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | -0.11 |
Allmed Solutions Leadership Team
Elected by the shareholders, the Allmed Solutions' board of directors comprises two types of representatives: Allmed Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allmed. The board's role is to monitor Allmed Solutions' management team and ensure that shareholders' interests are well served. Allmed Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allmed Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shay Arotchas, Vice President - Operations | ||
| Etan Hillman, External Director | ||
| Erez Keinan, Vice President - Finance | ||
| Ariel Rubashkin, Vice President - Finance | ||
| Abraham Nahmias, Chairman of the Board | ||
| Jacob Dagan, Independent Director | ||
| Assaf Alperovitz, Chief Executive Officer | ||
| Daniel Spira, Internal Auditor | ||
| Oz Shapira, Chief Officer | ||
| Rinat Gazit, External Director | ||
| Shai Tag, Finance Director | ||
| Ziv Kalfon, Vice President-Engineering & Technology | ||
| David Milch, Director | ||
| Ehud Geller, Director | ||
| Eitan Hod, VP RA | ||
| David MD, Founder Chairman |
Allmed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Allmed Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (36.89) % | |||
| Current Valuation | 13.15 M | |||
| Shares Outstanding | 80.82 M | |||
| Shares Owned By Insiders | 44.71 % | |||
| Price To Earning | 147.17 X | |||
| Price To Book | 0.51 X | |||
| Price To Sales | 85.68 X | |||
| Revenue | 5.54 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Allmed Stock
Allmed Solutions financial ratios help investors to determine whether Allmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allmed with respect to the benefits of owning Allmed Solutions security.